Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis
NCT01752335
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
OTHER:
Braquial ecography
Sponsor
Hospital Universitario de Canarias
Collaborators
[object Object]